Effect of Olea oleaster and Juniperus procera leaves extracts on thioacetamide induced hepatic cirrhosis in male albino mice  by Al-Attar, Atef M. et al.
Saudi Journal of Biological Sciences (2016) 23, 363–371King Saud University
Saudi Journal of Biological Sciences
www.ksu.edu.sa
www.sciencedirect.comORIGINAL ARTICLEEﬀect of Olea oleaster and Juniperus procera leaves
extracts on thioacetamide induced hepatic cirrhosis
in male albino mice* Corresponding author. Tel.: +966 504629915.
E-mail address: atef_a_2000@yahoo.com (A.M. Al-Attar).
Peer review under responsibility of King Saud University.
Production and hosting by Elsevier
http://dx.doi.org/10.1016/j.sjbs.2015.08.011
1319-562X  2015 Production and hosting by Elsevier B.V. on behalf of King Saud University.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Atef M. Al-Attar *, Ali A. Alrobai, Daklallah A. AlmalkiDepartment of Biological Sciences, Faculty of Sciences, King Abdulaziz University, P.O. Box 139109, Jeddah 21323, Saudi ArabiaReceived 5 July 2015; revised 13 August 2015; accepted 19 August 2015
Available online 28 August 2015KEYWORDS
Hepatic cirrhosis;
Thioacetamide;
Olea oleaster;
Juniperus procera;
MiceAbstract The effect of Olea oleaster and Juniperus procera leaves extracts and their combination
on thioacetamide (TAA)-induced hepatic cirrhosis were investigated in male albino mice. One
hundred sixty mice were used in this study and were randomly distributed into eight groups of
20 each. Mice of group 1 served as controls. Mice of group 2 were treated with TAA. Mice of group
3 were exposed to TAA and supplemented with O. oleaster leaves extracts. Mice of group 4 were
treated with TAA and supplemented with J. procera leaves extracts. Mice of group 5 were subjected
to TAA and supplemented with O. oleaster and J. procera leaves extracts. Mice of groups 6, 7 and 8
were supplemented with O. oleaster, J. procera, and O. oleaster and J. procera leaves extracts
respectively. Administration of TAA for six and twelve weeks resulted in a decline in body weight
gain and increased the levels of serum alanine aminotransferase, aspartate aminotransferase,
alkaline phosphatase and total bilirubin. Histopathological evaluations of hepatic sections from
mice treated with TAA showed severe alterations including increase of fibrogenesis processes with
structural damage. Treatment of mice with these extracts showed a pronounced attenuation in TAA
induced hepatic cirrhosis associated with physiological and histopathological alterations. Finally,
this study suggests that the supplementation of these extracts may act as antioxidant agents and
could be an excellent adjuvant support in the therapy of hepatic cirrhosis.
 2015 Production and hosting by Elsevier B.V. on behalf of King Saud University. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Liver, the largest gland in body, is vulnerable to a vast variety
of harmful endogenous and exogenous agents. Therefore, liver
is one of the most frequently injured organs in the body
(Sivaraj et al., 2011). A report of The World Health Organiza-
tion (WHO) indicates that 10% of the world population has
chronic liver disease, in addition about two million people
worldwide die each year from hepatic failure (Schuppan and
364 A.M. Al-Attar et al.Afdhal, 2008). Liver or hepatic fibrosis is a reversible physio-
logical wound-healing process. When damage is sustained,
however, this process becomes exacerbated and irreversible,
leading to cirrhosis (Ramachandran and Iredale, 2012).
Hepatic fibrosis after hepatocyte injury is a pathological
process with deposition of extracellular matrix (ECM) proteins
such as collagens (Lang et al., 2011). Despite the increasing
burden of this condition, treatment options for liver fibrosis
and its advanced lesion, cirrhosis, remain very limited.
Following liver damage, there is trans-differentiation of
hepatic stellate cells (HSCs) into ECM secreting myofibrob-
lasts (Friedman, 2008).
Thioacetamide (TAA) is a thiono-sulfur containing
compound. It has been used as a fungicide, organic solvent,
accelerator in the vulcanization of rubber, and as a stabilizer
of motor oil (Lee et al., 2003). TAA was first reported as a
hepatotoxic agent by Fitzhugh and Nelson (1948). The hepatic
toxic chemical TAA has been widely used in the study of the
underlying mechanisms of hepatic fibrogenesis and the
therapeutic effects of potential antifibrosis drugs. Additionally,
many experimental investigations showed that TAA
induced hepatic fibrosis and cirrhosis in rats and mice
(Al-Attar, 2011, 2012; Ali et al., 2014; Abdou et al., 2015;
Al-Attar and Shawush, 2015; Meng et al., 2015; Wang et al.,
2015).
Plants are a rich source of bioactive components that
have desirable health benefits and are traditionally known
to be useful for prevention of chronic diseases
(Yogalakshmi et al., 2010). Herbal medicines have been
reported to show protective effects from liver fibrosis and
injury (Hsieh et al., 2008; Yuan et al., 2008; Al-Attar,
2012; Saravanan et al., 2013; Ali et al., 2014; Abdou
et al., 2015; Al-Attar and Shawush, 2015). Olea oleaster cor-
responds to Olea europaea subsp. and those trees originated
in the eastern Mediterranean and south west of kingdom of
Saudi Arabia. It contains secoiridoids such as oleuropein,
ligostroside, dimethyl oleuropein and oleoside, flavonoids,
phenolic compounds, such as caffeic acid, tyrosol (El and
Karakaya, 2009). All previous studies carried out on
O. oleaster show that olive extracts are used for nutrients
that help fight against a variety of illnesses and control fat
and weight loss (Flynn and Reinert, 2010). Juniperus is
one of the major genera of Cupressaceae family. It is esti-
mated that 70 species of Juniperus are distributed through-
out the world (Topc¸u et al., 1999). Juniperus species are
used for the treatment of hyperglycemia, tuberculosis, bron-
chitis, pneumonia, ulcers, intestinal worms, to heal wounds
and cure liver diseases (Burits et al., 2001; Loizzo et al.,
2007). Moreover, the medical use of Juniperus is well known
in the Bosnian, Lebanese, and Turkish folk medicine and the
berries are used to treat skin diseases like skin rash and
eczema in addition to a wide range of respiratory tract dis-
eases, like asthma, common cold, cough, bronchitis, throat
inflammation, pneumonia and tuberculosis (El et al., 2008;
O¨ztu¨rk et al., 2011), urinary tract inflammations, renal and
gall bladder stones, and rheumatism (Sˇaric´ et al., 2011).
Therefore, the aim of this study was to find if the adminis-
tration of O. oleaster, J. procera leaves extracts and their
combination could have beneficial effects on experimental
liver cirrhosis induced by TAA in male albino mice.2. Materials and methods
2.1. Experimental animals
One hundred sixty male albino mice of the SWR strain, weigh-
ing 15.0–25.0 g used in this study were obtained from the
Experimental Animal Unit of King Fahd Medical Research
Center, King Abdulaziz University, Jeddah, Saudi Arabia.
Mice were housed 10 per cage in a room with 12/12-h light/
dark cycle at ambient temperature of 20 ± 1 C and humidity
of 65%. The experimental animals were acclimatized to the
laboratory conditions for one week prior to the initiation of
experimental treatments. Mice were fed ad libitum on normal
commercial chow and had free access to water. The experimen-
tal treatments were conducted in accordance with ethical
guidelines of the Animal Care and Use Committee of King
Abdulaziz University.
2.2. Extraction of O. oleaster and J. procera leaves
Fine qualities of O. oleaster and J. procera leaves were directly
collected from the outskirts of Albaha region of Saudi Arabia.
The leaves were scientifically defined by the herbarium of
Biological Sciences Department, Faculty of Sciences, King
Abdulaziz University, Jeddah, Saudi Arabia. The collected
leaves were completely washed, air dried at room temperature
and stored in a dry plastic container until use for extraction
processes. The method of Al-Attar and Abu Zeid (2013) was
used to prepare the extracts. The dried leaves of O. oleaster
(50 g) were powdered, added to 2 liters of cold water and
mixed using an electric mixer for 20 min. Also, the dried leaves
of J. procera (50 g) were powdered, added to 2 liters of cold
water and mixed using an electric mixer for 20 min. Thereafter,
the solutions of O. oleaster and J. procera leaves were gently
filtered. Finally, the filtrates were evaporated in an oven at
40 C to produce dried residues (active principles). With
references to the powdered samples, the mean yield of
O. oleaster and J. procera extracts was 19.3% and 17.8%
respectively. Furthermore, these extracts were stored in a
refrigerator for subsequent experiments.
2.3. Experimental protocol
The mice were randomly distributed into eight groups of 20
each. Mice of group 1 were served as controls and intraperi-
toneally injected with saline solution (0.9% NaCl), twice
weekly. Mice of group 2 were given 150 mg/kg body weight
of TAA (Sigma–Aldrich Corp., St. Louis, MO, USA) by
intraperitoneal injection, twice weekly. Mice of group 3 were
intraperitoneally injected with TAA at the same dose given to
group 2 and were orally supplemented with O. oleaster leaves
extract at a dose of 200 mg/kg body weight/day. Mice of group
4 were intraperitoneally injected with TAA at the same dose
given to group 2 and were orally supplemented with J. procera
leaves extract at a dose of 200 mg/kg body weight/day. Mice of
group 5 were intraperitoneally injected with TAA at the same
dose given to group 2 and were orally supplemented with
O. oleaster leaves extract (100 mg/kg body weight/day) and
J. procera leaves extract (100 mg/kg body weight/day). Mice
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same dose given to group 1 and were orally supplemented with
O. oleaster leaves extracts at the same dose given to group 3.
Animals of group 7 intraperitoneally received saline solution
at the same dose given to group 1 and were orally supplemented
with J. procera leaves extract at the same dose given to group 4.
Mice of group 8 intraperitoneally received saline solution at the
same dose given to group 1 and were supplemented with
O. oleaster and J. procera leaves extracts at the same dose given
to group 5. The body weights of mice were determined at the
start of the experimental period, after six and twelve weeks
using a digital balance. These weights were measured at the
same time during the morning (Al-Attar and Zari, 2010) and
the percentage changes of body weight after six and twelve
weeks were calculated. Moreover, the experimental animals
were observed for signs of abnormalities throughout the period
of study. After six and twelve weeks food was withdrawn from
the mice and they were fasted for 8 h but had free access to
water, and then anesthetized with diethyl ether. Blood
specimens were collected from orbital venous plexus in
non-heparinized tubes. Blood specimens were centrifuged at
2500 rpm for 15 min, and the clear samples of blood serum
were separated and stored at 80 C. These serum samples
were used to determine the levels of alanine aminotransferase
(ALT), aspartate aminotransferase (AST), alkaline phos-
phatase (ALP) and total bilirubin. The method of Reitman
and Frankel (1957) was used to determine the levels of serum
ALT and AST. The method of Szasz (1969) was used to mea-
sure the level of serum ALP. Serum level of total bilirubin
was estimated using the method of Doumas et al. (1973). For
histological examinations after six and twelve weeks, mice were
dissected after blood sampling. Liver tissues were quickly
isolated from each group, fixed in 10% buffered formalin,
sectioned and stained with haematoxylin and eosin.
Additionally, liver sections were stained using Masson’s
trichrome stain. All liver sections were examined using light
microscope (Olympus BX61 – USA) connected to motorized
controller unit (Olympus bx-ucb – USA) and photographed
by a camera (Olympus DP72 – USA).
2.4. Statistical analysis
The data were expressed as mean ± standard deviation (SD)
and were analyzed using the Statistical Package for Social
Sciences (SPSS for windows, version 12.0). Statistical compar-
isons were performed by a two-way analysis of variance
(ANOVA). The results were considered statistically significant
if the P-values were less than 0.05.3. Results
The body weights after six weeks of all experimental groups
are represented in Fig. 1. There was a gradual increase in the
body weight of normal control mice (122.8%) at the end of
six weeks compared with their initial body weights. Significant
decreases in the values of body weight gain were observed in
mice treated with TAA, TAA plus O. oleaster leaves extract,
TAA plus J. procera leaves extracts, and TAA plus O. oleaster
and J. procera leaves extracts. The minimum body weight gain
was noted in TAA-intoxicated mice (36.7%). Supplementation
with the tested extracts showed a remarkable lowering effecton the percentage changes of body weight in mice treated with
TAA plus O. oleaster leaves extracts, TAA plus J. procera
leaves extracts, and TAA plus O. oleaster and J. procera leaves
extracts which amounted 40.5%, 43.6% and 59.6% respec-
tively. Oral administration of tested extracts to normal mice
caused significant increases in body weight gain. The change
of body weight gain was 108.6% in normal mice supplemented
with O. oleaster leaves extract. Supplementation with
J. procera leaves extract in normal mice showed a remarkable
increase in the percentage change of body weight (112.6.4%).
The percentage change of body weight gain in normal mice
fed with O. oleaster and J. procera leaves extracts is 105.4%.
Fig. 2 demonstrates the body weights of all experimental
groups after twelve weeks. The maximum body weight gain
was noted in normal mice supplemented with J. procera leaves
extract (105.2%) followed by normal control mice (98.3%) and
mice treated with TAA plus J. procera leaves extract (96.1%).
The minimum body weight gain was noted in normal mice
treated with only TAA (79.7%). Notable decreases in the
values of body weight gain were observed in mice subjected
to TAA plus O. oleaster extract (85.3%), TAA plus O. oleaster
and J. procera leaves extracts (86.1%), O. oleaster extract
(88.2%) and O. oleaster and J. procera leaves extracts (86.6%).
Fig. 3A–D shows the level of serum ALT, AST, ALP and
total bilirubin in control, TAA, TTA plus O. oleaster
leaves extract, TAA plus J. procera leaves extract, TAA plus
O. oleaster and J. procera leaves extracts, O. oleaster leaves
extract, J. procera leaves extract, and O. oleaster and J. procera
leaves extracts treated mice after six weeks. Administration of
TAA (150 mg/kg) for six weeks resulted in a markedly high
increase (2046.3%) in the level of serum ALT compared with
control mice and other treated groups (Fig. 3A). A significant
increase in the level of serum ALT was noted in mice treated
with TAA plus O. oleaster leaves extract (127.6%), TAA plus
J. procera leaves extract (236.4%) and TAA plus O. oleaster
and J. procera leaves extracts (296.7%) compared with control
mice. The levels of serum AST after six weeks were statistically
increased in rats exposed to TAA (839.9%), TAA plus
O. oleaster leaves extract (179.2%) and TAA plus J. procera
leaves extract (195.0%) TAA plus O. oleaster and J. procera
leaves extracts (296.7%) as compared with control mice. In
comparison with control group, the level of serum ALP was
significantly increased after six weeks in mice exposed to
TAA (465.6%), TAA plus O. oleaster leaves extract
(334.1%) and TAA plus J. procera leaves extract (418.9%)
TAA plus O. oleaster and J. procera leaves extracts
(299.0%). The levels of serum total bilirubin were statistically
increased after six weeks in mice subjected to TAA (133.5%),
TAA plus O. oleaster leaves extract (29.6%), TAA plus
J. procera leaves extract (62.9%) and TAA plus O. oleaster and
J. procera leaves extracts (59.3%) compared with control mice.
Fig. 4A–D shows the level of serum ALT, AST, ALP and
total bilirubin in control, TAA, TAA plus O. oleaster leaves
extract, TAA plus J. procera leaves extract, TAA plus
O. oleaster and J. procera leaves extracts, O. oleaster leaves
extract, J. procera leaves extract, and O. oleaster and J. procera
leaves extracts treated mice after twelve weeks. Serum ALT
level was statistically enhanced after twelve weeks in mice trea-
ted with TAA (1632.0%), TAA plus O. oleaster leaves extract
(348.2%), TAA plus J. procera leaves extract (390.2%) and
TAA plus O. oleaster and J. procera leaves extracts (422.5%)
compared with control mice. In comparison with control
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Figure 1 Changes of body weight after six weeks in control (group 1), TAA (group 2), TAA plus O. oleaster leaves extract (group 3),
TAA plus J. procera leaves extract (group 4), TAA plus O. oleaster and J. procera leaves extracts (group 5), O. oleaster leaves extract
(group 6), J. procera leaves extract (group 7), and O. oleaster and J. procera leaves extracts (group 8) treated mice.
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Figure 2 Changes of body weight after twelve weeks in control (group 1), TAA (group 2), TAA plus O. oleaster leaves extract (group 3),
TAA plus J. procera leaves extract (group 4), TAA plus O. oleaster and J. procera leaves extracts (group 5), O. oleaster leaves extract
(group 6), J. procera leaves extract (group 7), and O. oleaster and J. procera leaves extracts (group 8) treated mice.
366 A.M. Al-Attar et al.values, the levels of serum AST were statistically increased
after twelve weeks in TAA (280.3%), TAA plus O. oleaster
leaves extract (88.9%) and TAA plus J. procera leaves extract
(89.1%) TAA plus O. oleaster and J. procera leaves extracts
(62.3%) treated mice. Significant elevations in the level of
serum ALP were observed in mice exposed to TAA
(1146.5%), TAA plus O. oleaster leaves extract (206.2%),
TAA plus J. procera leaves extract (270.9%), and TAA plus
O. oleaster and J. procera leaves extracts (299.0%) compared
with control mice. There were significant increases after twelve
weeks in the level of serum total bilirubin in mice subjected to
TAA (271.7%), TAA plus J. procera leaves extract (27.8%)
and TAA plus O. oleaster and J. procera leaves extracts
(31.9%) compared with control mice, while this parameter
was statistically unchanged in TAA plus O. oleaster leaves
extracts (Fig. 4D). The levels of serum ALT, AST, ALP and
total bilirubin were remarkably unchanged in normal micesupplemented with O. oleaster leaves extract, J. procera leaves
extract, and O. oleaster and J. procera leaves extracts after six
(Fig. 3A–D) and twelve (Fig. 4A–D) weeks.
Histopathological examination of liver sections from
control mice showed a normal hepatocellular architecture
(Fig. 5A). Similar observations were noted in O. oleaster leaves
extract (Figs. 5H and 6F), J. procera leaves extract
(Figs. 5I and 6G), and O. oleaster and J. procera leaves
extracts (Figs. 5J and 6H) treated mice after six and twelve
weeks. Photomicrographs from liver sections of mice exposed
to TAA for six weeks showed a structural damage with the
extracellular matrix collagen (Fig. 5B–D). Conversely, pho-
tomicrographs of liver sections from mice subjected to TAA
plus O. oleaster leaves extract (Fig. 5E), TAA plus J. procera
leaves extract (Fig. 5F), and TAA plus O. oleaster and
J. procera leaves extracts (Fig. 5G) shows a decreased
development of fibrogenesis processes. Liver sections from
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Figure 3 (A–D) The levels of ALT (A), AST (B), ALP (C) and total bilirubin (D) in serum from control, TAA, TAA plus O. oleaster
leaves extract, TAA plus J. procera leaves extract, TAA plus O. oleaster and J. procera leaves extracts, O. oleaster leaves extract, J. procera
leaves extract, and O. oleaster and J. procera leaves extracts treated mice for six weeks.
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alterations of tissue architecture and advanced fibrosis
with increases of extracellular matrix collagen content
(Fig. 6A and B). Administration of the studied extracts
attenuated the development of hepatic fibrosis induced by
TAA after twelve weeks (Fig. 6C–E).
4. Discussion
Liver or hepatic diseases resulting from liver damage is a
global problem. Among hepatic diseases, cirrhosis is an
important and common cause of human mortality in many
countries. It is the end-stage of most liver pathologies of
different etiologies and leads to chronic liver dysfunction,
accompanied by important metabolic alterations (Galisteo
et al., 2006). Cirrhosis of liver is a common end consequence
of a variety of chronic liver diseases. Its underlying pathology,
fibrosis, represents the common response of liver to toxic,
infectious, or metabolic agents (Schuppan and Kim, 2013).
Currently, hepatic fibrosis still contributes to the high
incidence and morbidity rates of cirrhosis as the latter is
irreversible. Thus, researchers are dedicated to find out specific
treatment targets that contribute to the development of hepatic
fibrosis (Qin et al., 2014).
The present study is the first experimental investigation
designed to evaluate whether supplementation of O. oleaster
leaves extract J. procera leaves extract, and O. oleaster and
J. procera leaves extracts would have protective influences on
TAA induced hepatic fibrosis and cirrhosis with physiologicaldisturbances and histological injuries in male mice.
TAA-induced hepatic fibrosis animal models must resemble
human ones in the hemodynamics, morphology and biochem-
ical metabolism aspects (Pietrangelo et al., 2007; Friedman,
2008), and also be similar to virus-induced cirrhosis
(Peng and Wang, 2010). Physiologically, it is known that
TAA toxicity is generally associated with hepatic fibrosis
induction, complicated metabolic disorders and health
problems (Al-Attar and Shawush, 2014). As seen in the present
study, the administration of TAA for six and twelve weeks that
TAA induced a notable decrease of body weight gain and
significantly increase of serum ALT, AST, ALP and total
bilirubin. Histopathologically, severe alterations of liver
structure with fibrogenesis processes were noted. Similar
observations were detected in many experimental studies on
TAA induced relative influences (Al-Attar, 2011, 2012;
Mustafa et al., 2013; Ali et al., 2014; Abdou et al., 2015;
Al-Attar and Shawush, 2015; Wang et al., 2015).
The present work showed that the treatment of mice with
O. oleaster and J. procera leaves extracts and their combina-
tion attenuated the physiological and histopathological
changes induced by TAA administration. Moreover, the most
improvements were observed in mice supplemented with
O. oleaster leaves extract followed by J. procera leaves extract
and their combination. This indicated the effectiveness of these
extracts in prevention of TAA toxicity. The main constituent
of the olive leaves is oleuropein, one of iridoide monoterpenes,
which is thought to be responsible for pharmacological effects.
Furthermore, the olive leaves contain triterpenes (oleanolic
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Figure 4 (A–D) The levels of ALT (A), AST (B), ALP (C) and total bilirubin (D) in serum from control, TAA, TAA plus O. oleaster
leaves extract, TAA plus J. procera leaves extract, TAA plus O. oleaster and J. procera leaves extracts, O. oleaster leaves extract, J. procera
leaves extract, and O. oleaster and J. procera leaves extracts treated mice for twelve weeks.
368 A.M. Al-Attar et al.and maslinic acid), flavonoids (e.g., luteolin, apigenin, rutin),
and chalcones (olivine, olivine-diglucoside) (Meirinhos et al.,
2005; Pereira et al., 2007). It is its chemical content that makes
olive leaves one of the most potent natural antioxidants.
Oleuropein has high antioxidant activity in vitro, comparable
to a hydrosoluble analog of tocopherol (Speroni et al., 1998),
as do other constituents of olive leaves (Briante et al., 2002).
It was shown that total olive leaves extract had antioxidant
activity higher than vitamin C and vitamin E, due to the
synergy between flavonoids, oleuropeosides and substituted
phenols (Benavente-Garcia et al., 2000).
Alirezaei et al. (2012) evaluated the antioxidant properties
of oleuropein on ethanol induced oxidative damage and its
beneficial effects on liver function of Sprague–Dawley male
rats. They reported that oleuropein during ethanol treatment
in rats resulted in a higher antiperoxidative enzyme activity,
catalase, and inhibited toxicity to the liver, as monitored by
the reduction in ALT and AST levels and thiobarbituric acid
reactive substance (TBARS) concentration. They suggested
that oleuropein possesses beneficial antioxidant effects against
ethanol-induced liver toxicity. Al-Attar and Shawush (2015)
investigated the influence of olive (Olea europaea) leaves
extract on TAA-induced hepatic cirrhosis in Wistar male rats.
They demonstrated that the extract of olive possesses hepato-
protective properties against TAA-induced hepatic cirrhosis by
inhibiting the physiological and histopathological alterations.
Moreover, they suggested that the hepatoprotective effects ofolive extract may be attributed to its antioxidant activity.
The petroleum ether fraction of J. procera showed significant
activity as hepatoprotective when investigated against CCl4
induced liver injury Wistar male rats (Alqasoumi and
Abdel-Kader, 2012). The hepatoprotective activity was evalu-
ated through the quantification of biochemical parameters
and confirmed using histopathology analysis. Different
fraction obtained from the aerial parts of J. phoenicea showed
significant activity as hepatoprotective when investigated
against CCl4 induced liver injury in Wistar male rats
(Alqasoumi et al., 2013). The hepatoprotective activity was
evaluated through the quantification of biochemical parame-
ters and confirmed using histopathological study.
In general, one of the most important findings in the pre-
sent study is the observation that the O. oleaster and J. procera
leaves extracts and their combination were effective in
attenuating the TAA induced hepatic fibrosis and cirrhosis
that were proven by hematobiochemical examinations and
histopathological evaluations. It may therefore be suggested
from the evidence from the present study, that the supplemen-
tations of the studied extracts may give some beneficial results
for people with some hepatic diseases. Moreover, this study
suggests that the supplementation of these extracts may act
as antioxidant agents and could be an excellent adjuvant
support in the therapy of hepatic fibrosis and cirrhosis induced
by TAA and different pathogens. Finally, further physiologi-
cal, biochemical and histopathological investigations using
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Figure 5 (A–J) Photomicrographs of liver sections in each group. (A) control (X400), (B, C and D) TAA (X100, X100 and X200), (E)
TAA plus O. oleaster leaves extract (X200), (F) TAA plus J. procera leaves extract (X200), (G) TAA plus O. oleaster and J. procera leaves
extracts (X200), (H) O. oleaster leaves extract (X400), (I) J. procera leaves extract (X400), and (J) O. oleaster and J. procera leaves extracts
(X400) treated mice for six weeks.
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Figure 6 (A–H) Photomicrographs of liver sections in treated groups. (A and B) TAA (X100 and X200), (C) TAA plus O. oleaster
leaves extract (X200), (D) TAA plus J. procera leaves extract (X200), (E) TAA plus O. oleaster and J. procera leaves extracts (X200),
(F) O. oleaster leaves extract (X400), (J) J. procera leaves extract (X400), and (H) O. oleaster and J. procera leaves extracts (X400) treated
mice for twelve weeks.
370 A.M. Al-Attar et al.different doses of these extracts are needed to find out the opti-
mal therapeutic doses and to explore the exact mechanism of
these extracts and their natural chemical constituents against
the fibrotic activity of TAA and its metabolites, and may be
against other related fibrogenic and pathogenic factors.
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